期刊文献+

游离钴显色率法自动检测缺血修饰清蛋白 被引量:1

Automated detection of ischemia modified albumin with free-cobalt coloration rate method
下载PDF
导出
摘要 目的 建立缺血修饰清蛋白(ischemia modified albumin,IMA)自动化检测方法;比较以游离钴显色率报告结果相对于吸光度单位(ABSU)的优缺点,并对112例健康对照和41例临床急性冠脉综合征(ACS)患者以及28例癫痫患者进行应用分析。方法 利用清蛋白结合重金属钴的能力随缺血修饰性清蛋白增加而下降,在480nm波长下,自动化连续监测反应体系中游离钴。结果 以游离钴显色率报告结果良好,线性范围广(回归方程:Y=0.955 2X=0.0134,r=0.9674,P〈0.01),最低生物检测限为10(ABSU:0.0635),批内及批间CV分别为0.85%和6.70%,在TG〈4.74mmol/L、Hb%15g/L时对结果无影响,与血清总胆红素(3.1~94.3μmol/L)和间接胆红素(1.6~35.0μmol/L)呈显著负相关(r=-0.8233,P〈0.01;r=-0.8504,P〈0.01),与直接胆红素(1.5~59.3μmol/L)无相关关系(r=-0.2006,P〉0.05)。以正常参考范围上限为界限(^-x+2s),游离钴显色率:59.35;ABSU:0.3768),诊断心肌缺血的阳性率和特异性分别达87.8%和92.1%。结论 以游离钴显色率方式建立的自动化检测清蛋白结合钴实验,排除了ABSU报告结果时722分光光度计不稳定和易受人为因素的影响,简单易行,抗干扰强,重复性好,线性范围广,灵敏度高,可大样本自动化检测,应用于临床,对ACS诊断和危险分层具有重要意义,可作为心肌缺血后标志性的生化指标来监测。 Objective To establish an automated detection method of ischemia modified albumin (IMA). The merits and demerits were compared between free-cobalt coloration rate and absorbance units, and applications of the former were analyzed in 112 normal controls, 41 patients with acute coronary syndrome (ACS) and 28 patients with epilepsy. Methods Utilizing the descent power of albumin binding cobalt along with the increase of ischemia modified albumin, free cobalt in reactive system were automatically and continuously detected under 480 nm wavelength, and results were reported in forms of absorbance unit (ABSU) and coloration rate of free cobalt. Results Free-cobalt coloration rate was reported accuracy, wide linear range (regression equation: Y = 0. 9552X - 0. 0134, r=0. 967 4,P〈0.01), and the lowest biological detected limit was 10(ABSU:0. 063 5). CV of intraand inter-batch was 0.85 % and 6.7 % respectively, and the results didn't alter markedly when TG〈4.74 mmol/L and Hb〈15 g/L, moreover it was significant negative correlative to TBil(3.1- 94.3 μmol/ L)(r=-0. 8233, P〈0.01) and IBil(1.6-35.0 μmol/L)(r=-0. 850 4, P〈0. 01). There was no correlation of IMA and DBil( 1.5- 59.3 μmol/L)(r= -0. 200 6, P〉0.05). Taking upper limit of normal reference range as threshold (coloration rate of free cobalt: 59.35;ABSU:0. 376 8), the positive rate and specificity of myocardial ischemia diagnosis was 87.80% and 92. 1% respectively. Conclusion Automated detection and results reported with coloration rate of free cobalt eliminating the influences of instable and artificial factors are simple and have stronger anti-jamming, better repeatability, wider linear range and higher sensitivity than manual method. Its clinical application is of importance in ACS diagnosis and risk demixing. IMA can be used as a potential biochemical criterion for myocardial ischemia.
出处 《国际检验医学杂志》 CAS 2007年第4期295-297,共3页 International Journal of Laboratory Medicine
关键词 心肌缺血 血清清蛋白 分光光度法 Myocardial ischemia Ischemia modified albumin Albumin in cobalt binding test
  • 相关文献

参考文献9

  • 1Bar-Or D, Curtis G, Rao N, et al. Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia [J]. Eur J Biochem, 2001, 268(1) : 42-47.
  • 2Bar-Or D, Lau E, Rao N, et al. Reduction in the cobalt binding capacity of human albumin with myocardial isehemia [J]. Ann Emerg Med,1999,34(4 Suppl) : S56.
  • 3王继贵,陈新瑞,胡敏.缺血修饰清蛋白测定及评价[J].临床检验杂志,2005,23(3):177-179. 被引量:7
  • 4Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report [J]. J Emerg Med, 2000, 19(4): 311-315.
  • 5Bhagavan NV, Lai EM, Rios PA, et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction [J]. Clin Chem, 2003, 49(4) : 581-585.
  • 6Christenson RH, Duh SH, Sanhai WR, et al. Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study [J]. Clin Chem, 2001, 47(3) : 464-470.
  • 7Bar-Or D, Winkler JV, Vanbenthuysen K, et al. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin Ⅰ[J]. Am Heart J, 2001, 141(6): 985-991.
  • 8Sinha MK, Gaze DC, Tippins JR, et al. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention [J]. Circulation, 2003, 107(19) : 2403-2405.
  • 9Apple FS, Quist HE, Otto AP, et al. Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race [J]. Clin Chem, 2002, 48(7): 1097-1100.

二级参考文献8

  • 1Bar-Or D, Lau E, Rao N, et al. Reduction in the cobalt binding capacity of human albumin with myocardial ischemia [ J ]. Ann Emerg Med, 1999,34 (4 Suppl): S56.
  • 2Sinha M K, Roy D, Gaze D C, et al. Role of" ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes[ J]. EMJ ,2004,21 ( 1 ) :29-34.
  • 3Christenson R H, Duh S H, Sanhai W R, et al. Characteristic of an albumin cobalt binding test for assessment of acute coronary syndrome patients: a multicenter study [ J ]. Clin Chem ,2001,47 ( 3 ) :464-470.
  • 4Jesse A, Fred A. New blood tests for detecting heart disease[J]. Circulation, 2004,109 ( 3 ): e12-e14.
  • 5Bar-Or D, Lau E, and Winkler J V. A novel assay for cobaltalbumin binding and its potential as a marker for myocardial ischemia-a preliminary report [ J]. J Emerg Med, 2000, 19(4) :311-315.
  • 6Bhagavan N V, Lai E M, Rios P A, et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction[J]. Clin Chem,2003,49(4) :581-585.
  • 7Bar-Or D, Winkler J V, Vanbenthuysen K, et al. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: A preliminary comparison to creatine kinaseMB, myoglobin, and troponin Ⅰ [ J ]. Am Heart J,2001,141(6) :985-991.
  • 8Bar-Or D, Curtis G, Rao N, et al. Characterization of the Co^2+ and Ni^2+ binding amino-acid residues of the Nterminus of human albumin-An insight into mechanism of a new assay for myocardial ischemia [ J ]. Eur J Biochem,2001,268( 1 ) :42-47.

共引文献6

同被引文献9

  • 1袁肇凯,黄献平,曹金枝,胡志希,简亚平.心肌缺血再灌注损伤大鼠冠状微循环改变的实验研究[J].中国微循环,2004,8(4):204-208. 被引量:16
  • 2吕永胜,李向平.缺血修饰性白蛋白在急性缺血性胸痛中的诊断价值[J].中国急救医学,2006,26(12):881-884. 被引量:6
  • 3Apple FS. Clinical and analytical review of ischemia - modified albumin measured by the albumin cobalt binding test [ J]. Adv Clin Chem ,2005,39( 1 ) : 1 - 10
  • 4Defilippi C, Yoon S, Ro A, et al. Early detection of myocardial ischemia by a novel blood based biomarker : the kinetics of ischemia modified albumin [ J]. JACC ,2003,41 (6suppl A) :340A
  • 5Sinha MK, Roy D, Gau DC, et al. Role of"Ischemia modified albumin", a new biochemical marker of myocardial ischemia, in the early diagnosis of acute coronary syndromes[ J]. Emerg Med J ,2004,21 (1) :29-34
  • 6Anwaruddin S, Januzzi JL Jr, Baggish AL, et al. Ischemia - modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting [J]. Am J Clin Pathol,2005,123(3) :140 - 145
  • 7Gidenne S, Ceppa F, Fontan E, et al. analytical performance of the albumin cobalt binding test on the cobas MIRA plus analyzer[J]. Clin Chem Lab Med,2004,42 ( 6 ) :455 - 461
  • 8Bhagavan NV, Lai EM, Rios PA, et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction [ J ]. Clin Chem, 2003,49 (4) : 581-585
  • 9张明,童静,应斌宇,唐疾飞,龚永生,练红,范小芳,杨鹏麟.大鼠心肌缺血/再灌注损伤及预处理apelin的表达[J].中国微循环,2007,11(5):296-299. 被引量:1

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部